InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.020
-0.030 (-2.86%)
At close: Jun 5, 2026, 4:00 PM EDT
0.9703
-0.0500 (-4.87%)
After-hours: Jun 5, 2026, 6:50 PM EDT
InterCure Balance Sheet
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 46.47 | 78.32 | 101.14 | 232.59 | 196.22 |
Short-Term Investments | 0.21 | 0.33 | 0.19 | 0.21 | 0.33 |
Cash & Short-Term Investments | 46.68 | 78.65 | 101.33 | 232.79 | 196.55 |
Cash Growth | -40.66% | -22.38% | -56.47% | 18.44% | 413.66% |
Accounts Receivable | 21.18 | 51.85 | 60.41 | 36.92 | 17.41 |
Other Receivables | 138.8 | 134.66 | 141.12 | 97.38 | 33.24 |
Total Trade Receivables | 159.97 | 186.51 | 201.53 | 134.29 | 50.65 |
Inventory | 108.06 | 125.33 | 106.29 | 146.5 | 67.88 |
Other Current Assets | 2.03 | 1.32 | 9.66 | 13.91 | 21.08 |
Total Current Assets | 316.75 | 391.8 | 418.8 | 527.49 | 336.16 |
Net Property, Plant & Equipment | 102.81 | 105.24 | 97.47 | 103.13 | 86.51 |
Goodwill | 219.19 | 224.59 | 221.08 | 284.18 | 268.29 |
Long-Term Investments | 1.02 | 2.15 | 1.92 | 2.57 | 2.57 |
Other Long-Term Assets | 50.78 | 38.79 | 28.89 | 20.64 | 3.02 |
Total Assets | 690.55 | 762.57 | 786.61 | 958.01 | 696.55 |
Accounts Payable | 68.14 | 77.54 | 78.44 | 126.07 | 64.47 |
Accrued Expenses | 43.45 | 41.81 | 55.15 | 48.4 | 41.05 |
Short-Term Debt | 11 | - | - | 1.09 | 1.72 |
Current Portion of Long-Term Debt | 88.8 | 69.44 | 88.19 | 126.94 | 70.56 |
Other Current Liabilities | 2.97 | 37.97 | 4.08 | 10.23 | 15.78 |
Total Current Liabilities | 214.37 | 226.75 | 225.87 | 312.72 | 193.59 |
Long-Term Debt | 59.46 | 113.98 | 82.2 | 99.68 | 11.95 |
Long-Term Leases | 19.49 | 23.2 | 20.64 | 23.1 | 21.37 |
Other Long-Term Liabilities | 0.88 | 0.97 | 0.84 | 1.03 | 0.22 |
Total Long-Term Liabilities | 79.83 | 138.15 | 103.68 | 123.81 | 33.55 |
Total Liabilities | 294.2 | 364.9 | 329.55 | 436.53 | 227.13 |
Additional Paid-in Capital | 695.19 | 658.6 | 643.16 | 640.57 | 632.11 |
Accumulated Other Comprehensive Income | 15.95 | 15.95 | 15.95 | 2.39 | 2.39 |
Retained Earnings | -314.62 | -277.58 | -204 | -141.65 | -186.47 |
Total Common Shareholders' Equity | 396.52 | 396.97 | 455.11 | 501.31 | 448.03 |
Minority Interest | -0.16 | 0.7 | 1.95 | 20.17 | 21.38 |
Shareholders' Equity | 396.36 | 397.67 | 457.06 | 521.48 | 469.41 |
Total Liabilities & Equity | 690.55 | 762.57 | 786.61 | 958.01 | 696.55 |
Total Debt | 178.75 | 206.62 | 191.04 | 250.81 | 105.61 |
Net Cash (Debt) | -132.08 | -127.96 | -89.71 | -18.02 | 90.94 |
Net Cash Growth | - | - | - | - | 181.41% |
Net Cash Per Share | -2.46 | -2.79 | -1.97 | -0.40 | 2.23 |
Book Value | 396.52 | 396.97 | 455.11 | 501.31 | 448.03 |
Book Value Per Share | 7.38 | 8.65 | 9.99 | 11.05 | 10.97 |
Tangible Book Value | 177.33 | 172.38 | 234.03 | 217.12 | 179.74 |
Tangible Book Value Per Share | 3.30 | 3.76 | 5.14 | 4.79 | 4.40 |